Nanoscale Coatings for Ultralow Dose BMP‐2‐Driven Regeneration of Critical‐Sized Bone Defects

While new biomaterials for regenerative therapies are being reported in the literature, clinical translation is slow. Some existing regenerative approaches rely on high doses of growth factors, such as bone morphogenetic protein‐2 (BMP‐2) in bone regeneration, which can cause serious side effects. A...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Adv Sci (Weinh)
Main Authors: Cheng, Zhe A., Alba‐Perez, Andres, Gonzalez‐Garcia, Cristina, Donnelly, Hannah, Llopis‐Hernandez, Virginia, Jayawarna, Vineetha, Childs, Peter, Shields, David W., Cantini, Marco, Ruiz‐Cantu, Laura, Reid, Andrew, Windmill, James F. C., Addison, Elena S., Corr, Sandra, Marshall, William G., Dalby, Matthew J., Salmeron‐Sanchez, Manuel
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Full Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6343071/
https://ncbi.nlm.nih.gov/pubmed/30693176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.201800361
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares